VF
MGRX icon

Virtu Financial’s Mangoceuticals MGRX Stock Holding History

Virtu Financial’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22K Buy
61,028
+27,566
+82% +$13.2K ﹤0.01% 1387
2025
Q4 		$25K Buy
+33,462
New +$54.3K ﹤0.01% 1390
2025
Q1 		– Sell
-20,501
Closed -$50K – 1764
2024
Q4 		$50K Buy
20,501
+19,245
+1,532% +$50.4K ﹤0.01% 1162
2024
Q3 		$4K Sell
1,256
-5,324
-81% -$25.1K ﹤0.01% 1255
2024
Q2 		$30K Buy
+6,580
New +$30.5K ﹤0.01% 978
2023
Q4 		– Sell
-1,565
Closed -$21K – 1841
2023
Q3 		$21K Buy
+1,565
New +$29.3K ﹤0.01% 1010

Other funds holding MGRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $488M AUM 14.36% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Virtu Financial's MGRX Position: Q1 2026 in Review

Virtu Financial increased its Mangoceuticals (MGRX) stake by 82% in Q1 2026, buying an estimated $13.2K and bringing the position to 61,028 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

Virtu Financial first reported a position in MGRX in Q3 2023 and has held it in 6 quarters since. The position peaked at $50K in Q4 2024. 18 funds tracked by Wall St. Rank hold MGRX as of Q1 2026.

  • Virtu Financial held 61,028 shares of Mangoceuticals worth $22K as of Q1 2026.
  • Virtu Financial bought 27,566 Mangoceuticals shares in Q1 2026, an estimated $13.2K.
  • Mangoceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1387 holding.
  • Virtu Financial first reported a position in Mangoceuticals in Q3 2023 and has held it in 6 quarters since.
  • Virtu Financial's Mangoceuticals position peaked at $50K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.